Australia Boosts Defense Capabilities with $930M Ghost Bat Drone Deal
Australia has sealed a $930 million contract with Boeing Defence Australia to acquire six Ghost Bat drones, marking Australia's first military aircraft design in over 50 years. This agreement highlights Australia's expanding defense spending and collaboration with the U.S. on advanced military technologies.
- Country:
- Australia
Australia has signed a $930 million deal with Boeing Defence Australia for the procurement of six Ghost Bat drones, as revealed on Tuesday. This purchase follows a successful live weapon test, marking a significant milestone as Australia designs its first military aircraft in more than five decades.
This development occurred alongside discussions between Australian and U.S. defense and foreign ministers in Washington, focusing on joint production of hypersonic cruise missiles in Australia. As part of the strengthening alliance, more rotations of U.S. bomber aircraft are expected in the region, with the U.S. encouraging Australia to boost its defense expenditure.
Australia's Defense Minister Richard Marles emphasized the increased military capabilities these drones will bring, especially after the recent AIM-120 missile test. With plans to spend A$10 billion on drones over the next decade, Australia is set to expand its military presence, particularly in its northern regions. The integration of autonomous technology for territorial defense remains a priority for the Australian Defence Force.
(With inputs from agencies.)
ALSO READ
Tri-Service ‘Ran Samwad’ 2026 to be Held; Signals Shift in India’s Military Strategy
Israel's military says it killed leader of Iranian Revolutionary Guard's undercover unit in its expeditionary Quds Force, reports AP.
Iran's Revolutionary Guard says an attack has killed the head of intelligence for the paramilitary organisation, reports AP.
Germany's New Military Service Law: A Controversial Clause
Rajnath Singh Launches Advanced Military Medical Centres, Pushes for Research-Led Healthcare and Pharma Innovation

